Clinical Trial Update: Evaluation of Serum Prostatic Specific Antigen (PSA) After Cyproterone Compound Treatment Compared With Oral Contraceptives Pill in Hirsute Polycystic Ovary Syndrome Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update comparing cyproterone acetate treatment to combined oral contraceptives for hirsute Polycystic Ovary Syndrome in Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Cyproterone acetate (cyproterone acetate)
• Oral Contraceptive Pill (oral contraceptive pill)

Snippet

Sponsor: Shahid Beheshti University | Conditions: Polycystic Ovary Syndrome | Phase 2, Phase 3 | Status: UNKNOWN